LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,762,091 | -34.6% | 57,558,451 | 0.0% | 2.86% | -24.7% |
Q2 2023 | $131,233,268 | +16.3% | 57,558,451 | 0.0% | 3.80% | +14.0% |
Q1 2023 | $112,814,563 | +19.5% | 57,558,451 | 0.0% | 3.33% | +25.7% |
Q4 2022 | $94,395,859 | -18.0% | 57,558,451 | 0.0% | 2.65% | -20.7% |
Q3 2022 | $115,116,000 | -5.8% | 57,558,451 | +1.8% | 3.34% | -12.7% |
Q2 2022 | $122,170,000 | -41.5% | 56,560,211 | +0.4% | 3.83% | -8.6% |
Q1 2022 | $208,947,000 | -69.9% | 56,319,960 | -50.0% | 4.18% | -21.8% |
Q4 2021 | $693,862,000 | – | 112,639,920 | – | 5.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,282,084 | $4,564,000 | 4.10% |
Perceptive Advisors | 57,558,451 | $115,116,000 | 3.34% |
SCHF (GPE), LLC | 937,500 | $1,875,000 | 2.47% |
VR Adviser, LLC | 5,378,341 | $10,757,000 | 1.66% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,303,573 | $6,607,000 | 0.64% |
Affinity Asset Advisors, LLC | 550,000 | $1,095,000 | 0.31% |
22NW, LP | 141,223 | $282,000 | 0.16% |
MYDA Advisors LLC | 120,000 | $240,000 | 0.11% |
Logos Global Management LP | 307,908 | $616,000 | 0.08% |
Old Well Partners, LLC | 32,200 | $64,000 | 0.05% |